López-Lacort, Mónica; Muñoz-Quiles, Cintia; Mira-Iglesias, Ainara; López-Labrador, FXavier; Mengual-Chulia, Beatriz; Fernández-García, Carlos; Carballido-Fernández, Mario; Pineda-Caplliure, Ana; Mollar-Maseres, Juan; Benavent, Maruan-Shalabi; Sanz-Herrero, Francisco; Zornoza-Moreno, Matilde; Pérez-Martin, Jaime-Jesús; Alfayate-Miguelez, Santiago; Crespo, Rocio-Pérez; Sánchez, Encarnación-Bastida; Menasalvas-Ruiz, Ana-Isabel; Tellez-González, MaCinta; Soto, Samuel-Esquiva; Del-Toro-Saravia, Carlos; Sanz-Muñoz, Ivan; Eiros, José-María; Del-Pozo, Vanesa-Matias; Toquero-Asensi, Marina; Pastor-Villalba, Eliseo; Lluch-Rodrigo, José-Antonio; Diez-Domingo, Javier; Orrico-Sánchez, Alejandro
(European Centre for Disease Prevention and Control (ECDC), 2024)
The monoclonal antibody nirsevimab was at least 70% effective in preventing hospitalisations in infants with lower respiratory tract infections (LRTI) positive for respiratory syncytial virus (RSV) in Spain (Oct 2023-Jan ...